Advances in Treatment Bring New Hope
According to the South China Morning Post, advances in the early diagnosis and treatment of Alzheimer’s disease are offering new hope to patients in Hong Kong. New therapies are helping slow cognitive decline during the early stages of the disease, allowing patients to maintain their independence and spend more meaningful time—described by specialists as “golden hours”—with their families before symptoms become more severe.
An Ageing Population Increases the Challenge
Hong Kong’s rapidly ageing population is contributing to a growing number of dementia cases. Approximately 9.7% of residents aged 60 and older are living with dementia, and experts project that the number of cases could reach 330,000 by 2039. This demographic trend is placing increasing pressure on healthcare services, caregivers and long-term care systems.
Early Diagnosis Is Critical
Medical specialists emphasize that early screening allows patients to benefit from recently developed treatments before significant brain damage occurs. New anti-amyloid therapies can modestly slow disease progression in selected patients, extending the period during which they can communicate, perform daily activities and maintain relationships with loved ones. However, experts stress that these medications are not a cure and require careful patient selection and monitoring.
Families and Healthcare Systems Need Greater Support
Beyond medical treatment, the report highlights the importance of expanding caregiver support, improving access to diagnostic services and reducing waiting times for specialist consultations. Families caring for Alzheimer’s patients often experience significant emotional, physical and financial burdens, making comprehensive public health policies essential as populations continue to age.
A Global Public Health Challenge
The experience in Hong Kong reflects challenges faced by many countries with ageing populations. Governments worldwide are investing in research, early detection programs and innovative treatments to delay cognitive decline while preparing healthcare systems for rising dementia cases. As life expectancy increases, Alzheimer’s disease is expected to become an even greater public health priority.
International Relevance
Overall, the South China Morning Post highlights how advances in Alzheimer’s diagnosis and treatment can improve patients’ quality of life while also exposing the broader challenges associated with population ageing. For the OGU, the topic is internationally relevant because it connects public health, demographic change, medical innovation, ageing societies and healthcare policy.
Reference: South China Morning Post. (2026, July 26). How can Alzheimer’s patients in Hong Kong buy more ‘golden hours’ with family? https://www.scmp.com/news/hong-kong/health-environment/article/3361854/how-can-alzheimers-patients-hong-kong-buy-more-golden-hours-family?share=FB2HSro%2Fy9g03eJB3tsgrnRJYeD8HfENe%2BA3xLxfXubwapgW24oYGk700Y3YQgFkv0M55cN4Gs%2FtrQpx5Vh7XiY4%2F75edO%2FF51GrLgcZPdo%3D&utm_campaign=social_share